Cargando…
Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro
Chemotherapy plays a major role in the treatment of cancer, but it still has great limitations in anti-tumor effect. Carboplatin (CAR) is the first-line drug in the treatment of non-small cell lung cancer, but the therapeutic effect is demonstrated weak. Therefore, we modified CAR with hexadecyl cha...
Autores principales: | Lang, Tingting, Li, Nuannuan, Zhang, Jing, Li, Yi, Rong, Rong, Fu, Yuanlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238065/ https://www.ncbi.nlm.nih.gov/pubmed/34176381 http://dx.doi.org/10.1080/10717544.2021.1938754 |
Ejemplares similares
-
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
por: Li, Nuannuan, et al.
Publicado: (2021) -
Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy
por: Fu, Yuanlei, et al.
Publicado: (2023) -
In vivo and in vitro evaluation of dihydroartemisinin prodrug nanocomplexes as a nano-drug delivery system: characterization, pharmacokinetics and pharmacodynamics
por: Ren, Guolian, et al.
Publicado: (2020) -
Magnetic delivery of antitumor carboplatin by using PEGylated-Niosomes
por: Davarpanah, Fereshteh, et al.
Publicado: (2018) -
Redox-Responsive Lipidic Prodrug Nano-Delivery System Improves Antitumor Effect of Curcumin Derivative C210
por: Guo, Xin, et al.
Publicado: (2023)